| The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides ARM Townsend, J Rothbard, FM Gotch, G Bahadur, D Wraith, ... Cell 44 (6), 959-968, 1986 | 2151 | 1986 |
| Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention H Acha-Orbea, DJ Mitchell, L Timmermann, DC Wraith, GS Tausch, ... Cell 54 (2), 263-273, 1988 | 1194 | 1988 |
| IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+ CD25+ regulatory T cells PL Vieira, JR Christensen, S Minaee, EJ O’Neill, FJ Barrat, A Boonstra, ... The Journal of Immunology 172 (10), 5986-5993, 2004 | 895 | 2004 |
| Symptoms and risk factors for long COVID in non-hospitalized adults A Subramanian, K Nirantharakumar, S Hughes, P Myles, T Williams, ... Nature medicine 28 (8), 1706-1714, 2022 | 561 | 2022 |
| Low avidity recognition of self-antigen by T cells permits escape from central tolerance GY Liu, PJ Fairchild, RM Smith, JR Prowle, D Kioussis, DC Wraith Immunity 3 (4), 407-415, 1995 | 527 | 1995 |
| Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy DC Wraith, DE Smilek, DJ Mitchell, L Steinman, HO McDevitt Cell 59 (2), 247-255, 1989 | 503 | 1989 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 476 | 2021 |
| Regulation of adaptive immunity; the role of interleukin-10 THS Ng, GJ Britton, EV Hill, J Verhagen, BR Burton, DC Wraith Frontiers in immunology 4, 129, 2013 | 445 | 2013 |
| Vaccination and autoimmune disease: what is the evidence? DC Wraith, M Goldman, PH Lambert The Lancet 362 (9396), 1659-1666, 2003 | 442 | 2003 |
| Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ... Nature 379 (6563), 343-346, 1996 | 434 | 1996 |
| Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis RA O'Connor, CT Prendergast, CA Sabatos, CWZ Lau, MD Leech, ... The Journal of Immunology 181 (6), 3750-3754, 2008 | 408 | 2008 |
| Peptide-based therapeutic vaccines for allergic and autoimmune diseases M Larche, DC Wraith Nature medicine 11 (Suppl 4), S69-S76, 2005 | 405 | 2005 |
| Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. GF Hoyne, RE O'Hehir, DC Wraith, WR Thomas, JR Lamb The Journal of experimental medicine 178 (5), 1783-1788, 1993 | 395 | 1993 |
| Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo A Sundstedt, EJ O’Neill, KS Nicolson, DC Wraith The Journal of Immunology 170 (3), 1240-1248, 2003 | 333 | 2003 |
| Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity B Metzler, DC Wraith International immunology 5 (9), 1159-1165, 1993 | 326 | 1993 |
| A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. DE Smilek, DC Wraith, S Hodgkinson, S Dwivedy, L Steinman, ... Proceedings of the National Academy of Sciences 88 (21), 9633-9637, 1991 | 308 | 1991 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 286 | 2022 |
| SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study A Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ... Thorax 75 (12), 1089-1094, 2020 | 279 | 2020 |
| Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP B Manoury, D Mazzeo, L Fugger, N Viner, M Ponsford, H Streeter, ... Nature immunology 3 (2), 169-174, 2002 | 258 | 2002 |
| T cell recognition as the target for immune intervention in autoimmune disease DC Wraith, HO McDevitt, L Steinman, H Acha-Orbea Cell 57 (5), 709-715, 1989 | 256 | 1989 |
Johan VerhagenFAU Erlangen-NürnbergGeverifieerd e-mailadres voor uk-erlangen.de
